
Kilimanjaro Clinical Research Institute (KCRI) is a leading health research institution based in Moshi, northern Tanzania, dedicated to conducting high-quality biomedical, clinical, and public health research. The institute collaborates closely with national and international academic institutions, government agencies, and global health organizations to address priority health challenges in Tanzania and beyond. KCRI has extensive experience in infectious diseases including zoonoses, antimicrobial resistance, non-communicable diseases, maternal and child health, vaccinology, genomics, and implementation science. The institute operates state-of-the-art, Good Clinical Laboratory Practice (GCLP)-accredited research laboratories equipped for microbiology, molecular biology, clinical chemistry, hematology, parasitology, immunology, genomics, and biobanking, supported by experienced multidisciplinary scientists and research support staff.
The study is being conducted at Kilimanjaro Christian Medical Centre (KCMC), a tertiary referral hospital in northern Tanzania, under the coordination KCRI. The pilot site recruits adult patients from four therapeutic areas: cardiovascular diseases, endocrinology, immunology, and oncology. The target population comprises adult patients receiving care at KCMC for hypertension, type 2 diabetes mellitus, HIV infection, or cancer. These patient groups were selected because chronic disease management requires sustained adherence to medication and treatment plans, and non-adherence can lead to poorer clinical outcomes, increased healthcare utilization, and reduced quality of life.
Kilimanjaro Clinical Research Institute
Kilimanjaro Clinical Research Institute (KCRI) is a leading health research institution based in Moshi, northern Tanzania, dedicated to conducting high-quality biomedical, clinical, and public health research. The institute collaborates closely with national and international academic institutions, government agencies, and global health organizations to address priority health challenges in Tanzania and beyond. KCRI has extensive experience in infectious diseases including zoonoses, antimicrobial resistance, non-communicable diseases, maternal and child health, vaccinology, genomics, and implementation science. The institute operates state-of-the-art, Good Clinical Laboratory Practice (GCLP)-accredited research laboratories equipped for microbiology, molecular biology, clinical chemistry, hematology, parasitology, immunology, genomics, and biobanking, supported by experienced multidisciplinary scientists and research support staff.
The study is being conducted at Kilimanjaro Christian Medical Centre (KCMC), a tertiary referral hospital in northern Tanzania, under the coordination KCRI. The pilot site recruits adult patients from four therapeutic areas: cardiovascular diseases, endocrinology, immunology, and oncology. The target population comprises adult patients receiving care at KCMC for hypertension, type 2 diabetes mellitus, HIV infection, or cancer. These patient groups were selected because chronic disease management requires sustained adherence to medication and treatment plans, and non-adherence can lead to poorer clinical outcomes, increased healthcare utilization, and reduced quality of life.
The primary aim of the end user personas is to support the creation of materials to support the implementation of the BEAMER model framework and to help define requirements for the elements of the BEAMER model framework. Hence, healthcare professionals (HCPs) represent the primary envisaged end user group of the BEAMER model framework and the associated Adherence Intelligence Visualisation Platform (AIVP)
It is one learning from the joint design process that the job titles of healthcare professional team members do not necessarily predict the roles they would play within the change management process for implementing BEAMER and installing it as a standard model within healthcare. Additionally, the role and responsibilities of certain job titles, for example nurse, varies across different healthcare systems and would affect how they interact with the BEAMER model outputs and the access they would be permitted and so it would not be helpful to include these job titles: The four personas represent role-independent archetypes within the group of HCPs. They encompass a Managerial HCP Persona, an Implementer HCP Persona, a Support HCP Persona, and a Established HCP Persona.
These healthcare professional personas may be further tailored to specific healthcare settings depending on the needs of the individual pilot sites. Thus, adapted or spin-off versions of these original personas may be considered. The persona displays include a summarising statement, goals, challenges, experience, and needs to enhance the accessibility and usability of the model while minimising user burden.
Patient organisations are considered potential users of the model outputs. Consequently, personas were designed for these groups to assure that the implementation materials may also support their needs in the longer term, thus fostering sustainability of the project outputs.
The identified focus areas within this persona are goals, needs, skills and tools, along with potential challenges anticipated during the implementation process. The persona emphasises awareness-raising, capacity building, education, peer support provision, and the promotion of research and development in therapeutic care.
The patient organisation persona serves as a theoretical framework representing how patient organisations could benefit from and include the BEAMER model framework in their therapy and care related as well as their organisational work. This persona comprises the needs, goals, challenges and necessary tools, facilitating preparation and implementation of the model and optimising the user experience of patient organisations as end users of the BEAMER model framework. It can be used as a guide to identify potential obstacles and understand the prerequisites for a patient organisation to successfully adopt and integrate the BEAMER model framework.
“In implementing the BEAMER model, we want to be able to respond to the different needs of our patients to ensure their adherence, build a supportive community and improve outcomes.”